Press release
Surgical Site Infections Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Destiny Pharma plc, POLYPID, Exoxemis, Covira Surgical, Inc., Eupraxia Pharmaceu
Surgical Site Infections Clinical Trials
According to DelveInsight, the Surgical Site Infections pipeline involves over 5 leading companies actively developing more than 5 therapeutic candidates for the treatment of Surgical Site Infections.
Surgical Site Infections Overview:
A surgical site infection (SSI) is an infection that occurs at the location of a surgical procedure. SSIs can vary in severity, ranging from minor infections affecting only the skin to more serious cases involving deeper tissues, organs, or implanted medical devices. The CDC provides guidelines and resources to help healthcare professionals prevent SSIs and educate the public on reducing their risk.
Symptoms usually appear within 5 to 7 days after surgery but can develop up to three weeks later, especially when a prosthetic implant is involved. Common indicators include spreading redness (erythema), localized pain, pus or discharge from the wound, and persistent fever (pyrexia).
Request for a detailed insights report on Surgical Site Infections pipeline insights [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
"Surgical Site Infections Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Surgical Site Infections Therapeutics Market.
Key Takeaways from the Surgical Site Infections Pipeline Report
*
DelveInsight's Surgical Site Infections (SSI) pipeline report highlights a developing landscape, with over 5 active companies working on more than 5 therapeutic candidates for SSI treatment.
*
Key players-including Destiny Pharma plc, POLYPID, Exoxemis, Covira Surgical, Eupraxia Pharmaceuticals, Sonoran Biosciences, and others-are exploring new drugs to enhance the SSI treatment landscape. Notable pipeline therapies in various stages of development include XF-73, D-PLEX100, and others.
*
In March 2025, PolyPid Ltd. announced the successful completion of patient enrollment for its SHIELD II Phase 3 trial, which is assessing the efficacy of D-PLEX, a novel therapy designed to prevent SSIs in patients undergoing abdominal colorectal surgeries with large incisions.
*
Additionally, a study published in March 2024 showed that implementing a straightforward pre-surgical infection prevention protocol significantly reduced severe post-surgical infections, highlighting the critical role of standardized preventive measures in surgical care.
Surgical Site Infections Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Surgical Site Infections Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Surgical Site Infections treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Surgical Site Infections market.
Download our free sample page report on Surgical Site Infections pipeline insights [https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Surgical Site Infections Emerging Drugs
*
XF-73: Destiny Pharma plc
*
D-PLEX100: POLYPID
Surgical Site Infections Companies
Over five leading companies are actively working on therapies for Surgical Site Infections (SSIs), with POLYPID having a drug candidate that has reached the most advanced stage of development, Phase III.
DelveInsight's report covers around 5+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Surgical Site Infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Surgical Site Infections Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Surgical Site Infections Therapies and Key Companies: Surgical Site Infections Clinical Trials and advancements [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Surgical Site Infections Pipeline Therapeutic Assessment
- Surgical Site Infections Assessment by Product Type
- Surgical Site Infections By Stage
- Surgical Site Infections Assessment by Route of Administration
- Surgical Site Infections Assessment by Molecule Type
Download Surgical Site Infections Sample report to know in detail about the Surgical Site Infections treatment market @ Surgical Site Infections Therapeutic Assessment [https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Surgical Site Infections Current Treatment Patterns
4. Surgical Site Infections - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Surgical Site Infections Late-Stage Products (Phase-III)
7. Surgical Site Infections Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Surgical Site Infections Discontinued Products
13. Surgical Site Infections Product Profiles
14. Surgical Site Infections Key Companies
15. Surgical Site Infections Key Products
16. Dormant and Discontinued Products
17. Surgical Site Infections Unmet Needs
18. Surgical Site Infections Future Perspectives
19. Surgical Site Infections Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Surgical Site Infections Pipeline Reports Offerings [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=surgical-site-infections-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-destiny-pharma-plc-polypid-exoxemis-covira-surgical-inc-eupraxia-pharmaceu]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surgical Site Infections Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Destiny Pharma plc, POLYPID, Exoxemis, Covira Surgical, Inc., Eupraxia Pharmaceu here
News-ID: 4162671 • Views: …
More Releases from ABNewswire
Frish Law Group APLC Provides Steadfast Personal Injury Advocacy in Hollywood Hi …
Los Angeles, CA - August 28, 2025 - In the heart of Los Angeles, traffic collisions, workplace accidents, and unexpected injuries can disrupt lives in an instant. For many residents of Hollywood Hills and Central LA, Frish Law Group, APLC has become a reliable source of legal support, offering compassionate guidance and effective representation when it matters most.
The firm is known not only for its courtroom skill but also for…
Frish Law Group APLC Highlights Dedication to Personal Injury Representation in …
Woodland Hills, CA - August 28, 2025 - For families in Woodland Hills, the days and weeks after an accident often come with medical appointments, insurance calls, and overwhelming uncertainty. During these moments, Frish Law Group, APLC has become a dependable ally, guiding injury victims through complex legal challenges and toward fair compensation.
The firm has developed a strong reputation in Los Angeles County by focusing on the details that matter…
Primary Biliary Cholangitis Clinical Trials, Companies, Therapeutic Assessment, …
DelveInsight's, "Primary Biliary Cholangitis (PBC)- Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Primary Biliary Cholangitis (PBC) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, the Primary Biliary Cholangitis…
Primary Hyperoxaluria Clinical Trials, Companies, Therapeutic Assessment, Therap …
DelveInsight's, "Primary Hyperoxyaluria - Pipeline Insight, 2025" report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Primary Hyperoxyaluria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, the Primary Hyperoxaluria pipeline features over 6…
More Releases for Surgical
Surgical Robotics Market to Witness Huge Growth by 2031 -Auris Surgical Robotics …
Surgical Robotics Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Surgical Robotics market emerge as the sector's next great thing? To discover the answer, look at the Surgical Robotics market analysis and projections. In-depth…
Surgical Laser Market - Shaping Surgical Precision: Surgical Laser, Guiding the …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Surgical Laser Market.
Surgical Laser Market: https://www.growthplusreports.com/report/surgical-laser-market/9172
The Surgical Laser Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Surgical Retractor Market - Enabling Surgical Mastery: Retractors for Uncompromi …
Newark, New Castle, USA: The "Surgical Retractor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Surgical Retractor Market: https://www.growthplusreports.com/report/surgical-retractor-market/7658
This latest report researches the industry structure, sales,…
Surgical Robots Market Hits USD 17,647.82 million by 2028 Lead By THINK Surgical …
There is a rise in the number of surgeries performed across the world. In the last 25 years, the incidence of cardiovascular diseases has increased globally. The rise in diabetic cases and lifestyle changes are leading to an increase in the number of cardiovascular surgeries and general surgeries. For instance, colorectal cancer is one of the most commonly found and lethal cancers developed in individuals due to the combined influence…
Surgical Robots Market Analysis 2020 - How COVID19 Impacting Surgical Robots Ind …
Report Analyzes Surgical Robots Market Size, Share and Industry Analysis By Type (Implantable Cardioverter Surgical Robots (ICD), Transvenous ICD, External Surgical Robots) By End User (Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Regional Forecast, 2019 - 2026.
Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/surgical-robots-market-100948
Key Players: Intuitive Surgical, Medtronic, Stryker, Smith & Nephew, Zimmer Biomet, TransEnterix Surgical, Inc Verb Surgical, THINK Surgical.
An…
Surgical Microscope Market Size, Surgical Microscope Market Share, Surgical Micr …
The global surgical microscope market was valued at USD 610.3 million in 2017 and is estimated to grow at a CAGR of 12.5% during the forecast period 2017-2026.
Request for Sample of This Research Report @ https://bit.ly/2xjcXML
Top Key Players:-
Carl Zeiss AG,
Leica Microsystems,
Takagi Corporation,
Seiler Precision Microscopes,
Topcon Corporation,
Alltion (Wuzhou) Co. Ltd.,
Alcon Laboratories, Inc.,
Haag-Streit Surgical,
Olympus Corporation,
Accu-scope, Inc.,
Novartis AG,
Danaher Corporation,
Labomed Microscopes,
Prescott’s Inc.,…
